📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. (2016)

First Author: McAllister-Williams RH

Attributed to: Antiglucocorticoid augmentation of antiDepressants in Depression (The ADD study) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(15)00436-8

PubMed Identifier: 26727041

Publication URI: http://europepmc.org/abstract/MED/26727041

Type: Journal Article/Review

Volume: 3

Parent Publication: The lancet. Psychiatry

Issue: 2

ISSN: 2215-0366